The Pharmaceutical Journal Vol 267 No 7178 p839-846
15 December 2001

This article
Reprint
Photocopy

News summary

Europe plans for bioterrorism risk

A European Union-wide strategy to guarantee the production, supply and availability of medicines warding off the effects of a biological terrorist attack has been debated at a meeting between the European Commission and the pharmaceutical industry. A policy paper on the subject is expected from the commission this winter.

Meanwhile, the commission has already set up a central group of nuclear, biological and chemical experts to assist EU member states in the event of a terrorist attack.

Back to Top